Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sangamo Therapeutics (SGMO) Exchange Rate Effect (2018 - 2025)

Sangamo Therapeutics has reported Exchange Rate Effect over the past 8 years, most recently at $40000.0 for Q4 2025.

  • Quarterly results put Exchange Rate Effect at $40000.0 for Q4 2025, up 101.78% from a year ago — trailing twelve months through Dec 2025 was $4.1 million (up 299.76% YoY), and the annual figure for FY2025 was $4.1 million, up 299.76%.
  • Exchange Rate Effect for Q4 2025 was $40000.0 at Sangamo Therapeutics, down from $42000.0 in the prior quarter.
  • Over the last five years, Exchange Rate Effect for SGMO hit a ceiling of $2.7 million in Q2 2025 and a floor of -$2.2 million in Q4 2024.
  • Median Exchange Rate Effect over the past 5 years was $128500.0 (2022), compared with a mean of $225850.0.
  • Biggest five-year swings in Exchange Rate Effect: crashed 533.07% in 2023 and later surged 1163.04% in 2025.
  • Sangamo Therapeutics' Exchange Rate Effect stood at -$115000.0 in 2021, then soared by 773.91% to $775000.0 in 2022, then surged by 74.58% to $1.4 million in 2023, then crashed by 266.08% to -$2.2 million in 2024, then skyrocketed by 101.78% to $40000.0 in 2025.
  • The last three reported values for Exchange Rate Effect were $40000.0 (Q4 2025), $42000.0 (Q3 2025), and $2.7 million (Q2 2025) per Business Quant data.